• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Development of NSAIDs that spare gastrointestinal tract injury.-COX-2 selective and NO-releasing NSAIDs-

Research Project

Project/Area Number 10557246
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field 応用薬理学・医療系薬学
Research InstitutionKyoto Pharmaceutical University

Principal Investigator

TAKEUCHI Koji  Kyoto Pharmaceutical University, Department of Pharmacology & Experimental Therapeutics, Professor, 薬学部, 教授 (00150798)

Co-Investigator(Kenkyū-buntansha) KATO Shinichi  Kyoto Pharmaceutical University, Department of Pharmacology & Experimental Therapeutics, Research Assocoate, 薬学部, 助手 (90281500)
Project Period (FY) 1998 – 1999
KeywordsUSAIDs / indomethacin / gastric lesion / small intestinal lesion / nitric oxide / 一酸化窒素
Research Abstract

The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a side array of alterations in gastrointestinal integrity and function. Various approaches have been taken to developing NSAIDs with reduced gastrointestinal toxicity, and few have been successfully reduced the incidence of adverse reactions. These include cyclooxygenase-2(COX-2) selective inhibitors and nitric oxide (NO)-releasing NSAIDs. In this study, we investigated the roles of COX and NO in housekeeping functions of the gastrointestinal mucosa in various circumstances, and the effects of gastrointestinal sparing NSAIDs(NO-aspirin and NO-indoemthacin), on the ulcerogenic and healing responses in the gastrointestinal mucosa of experimental animals, and obtained the following results;
1.Both indomethacin and aspirin are ulcerogenic by themselves and impair the healing of pre-existing gastric ulcers as well. The former action is due to inhibition of COX-1, while the latter effect may be acoounted for by inhibi … More tion of COX-2 and mimicked by NS-398, the COX-2 selective NSAID. NO-releasing NSAIDs such as NCX-4016 (aspirin derivative) or NCX-530 (indomethacin derivative), despite inhibiting both COX-1 and COX-2, protects the stomach against demage and preserves the healing response of gastric ulcers, probably because of the beneficial action of NO.
2. The pathogenic mechanism of indomethacin-induced small intestinal lesions involves superoxide radicals as well as NO produced by iNOS. The deleterious effect of NO may be accounted for by the cytotoxic action of peroxynitrite, produced from NO in the presence of superoxide radicals. The enterobacterial translocation in the mucosa in the first step required for activation of various factors such as iNOS/NO and neutrophils, and they are all involved in the pathogenesis of indomethacin-induced intestinal lesions. In addition, NO exerts a dual action in the pathogenesis of indomethacin-induced intestinal ulceration ; NO generated by cNOS is protective against indomethacin, by maintaining the integrity of intestinal mucosa, while NO derived by iNOS play a key pathogenic role in the ulcerogenic process. Less

  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Takeuchi K. et al.: "Effects of COX-2 selective and NO-releasing NSAIDs on gastric ulcerogenic responses"Journal of Physiology and Pharmacology. 49. 501-513 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Konaka A. et al.: "Nitric Oxide, superoxide radicals and mast cells in Pathogenesis of indomethacin-induced small intestinal lesions in rats"Journal of Physiology and Pharmacology. 50. 25-38 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] kato S. et al.: "Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis : Role of nitric oxide"Alimentary Pharmacology and Therapeutics. 13. 833-840 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Konaka A. et al.: "Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin lesions in rats"Pharmacological Research. 40. 517-524 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tanaka A. et al.: "Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats"Journal of Physiology and Pharmacology. 50. 405-417 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takeuchi K. et al.: "Gastrointestinal sparing anti-inflammatory drugs - Effects on ulcerogenic and healing responses-"Current Pharmaceutical Design (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kato S. et al.: "Alteration in gastric mucosal susceptibility to ulcerogenic stimulation in adjvant arthritis rats"Alimentary Pharmacology and Therapeutics. (in press).

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 鵜川英樹 (共著): "胃損傷の発生および治癒に対する一酸化窒素遊離型アスピリンの影響"Cyto-protection & biology. 17. 65-69 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 古仲晃 (共著): "インドメタシン誘起小腸傷害の発生と一酸化窒素、好中球、活性酸素および肥満細胞の関連"Cyto-protection & biology. 17. 71-74 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 田中晶子 他(共著): "胃粘膜防御機構におけるカプサイシン感受性知覚神経の役割"医薬ジャーナル社(三輪剛 監 竹内孝治 編). 131 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koji Takeuchi, Keizo Suzuki, Hideichiro Yamamoto, Hideo Araki, Hieroyuki Mizoguchi and Hideki Ukawa: "Effects of COX-2-selective and NO-releasing NSAIDs on gastric ulcerogenic responses."Journal of Physiology and Pharmacology. Vol. 49. 501-513 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akira Konaka, Masahito Nishijima, Akiko Tanaka, Tomonori Kunikata, Shinichi Kato and Koji Takeuchi: "Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats."Journal of Physiology and Pharmacology. Vol. 50. 25-38 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shinichi Kato, Akiko Tanaka, Akira Konaka, Tomonori Kunikata and Koji Takeuchi: "Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis : Role of nitric oxide."Alimentary Pharmacology and Therapeutics. Vol. 13. 833-840 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akira Konaka, Shinichi Kato, Akiko Tanaka, Tomonori Kunikata, R. Korolkiewicz and Koji Takeuchi: "Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin lesions in rats."Pharmacological Research. Vol. 40. 517-524 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Akiko Tanaka, Tomonori Kunikata, Akira Konaka, Shinichi Kato and Koji Takeuchi: "Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats."Journal of Physiology and Pharmacology. Vol. 50. 405-417 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koji Takeuchi, Akiko Tanaka, Keizo Suzuki, Hiroyuki Mizoguchi: "Gastrointestinal sparing anti-inflammatory drugs-Effects on ulcerogenic and healing responses."Current Pharmaceutical Design. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Shinichi Kato, Akiko Tanaka, Tomonori Kunikata, Hiroyuki Mizoguchi and Koji Takeuchi: "Alteration in gastric mucosal susceptibility to ulcerogenic stimulation in adjvant arthritis rats."Alimentary Pharmacology and Therapeutics. (in press).

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi